FindTrial
Sign In

Research on the Mechanism of Escaping the CRISPR-Cas Defense System of Pseudomonas aeruginosa by Carrying the blaKPC-2 Plasmid

Research on the Mechanism of Escaping the CRISPR-Cas Defense System of Pseudomonas aeruginosa by Carrying the blaKPC-2 Plasmid

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122180
Enrollment
Unknown
Registered
2026-04-09
Start date
2026-05-15
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carbapenem-resistant Pseudomonas aeruginosa infection

Interventions

CRISPR-Cas positive and CRISPR-Cas negative CRPA:None

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Carbonic acid meningylase-resistant Pseudomonas aeruginosa was identified through clinical drug sensitivity tests;

Exclusion criteria

Exclusion criteria: 1.All clinical strains were identified using the VITEK2 system, and duplicate strains and those from unqualified specimens were excluded.

Design outcomes

Primary

MeasureTime frame
Genome sequencing results;—

Countries

China

Contacts

Public ContactAn Xu

Shenzhen People's Hospital

anxu_shift625@sina.com+86 755 25533018

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026